Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Heatwave
Ramzan
Coronavirus Cases In India
COVID-19 Vaccination
Fuel Price Hike
COVID-19 Guidelines
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / India News / Government panel recommends 12-16 week gap between Covishield doses
India

Government panel recommends 12-16 week gap between Covishield doses

Government panel recommends 12-16 week gap between Covishield doses
Written by Siddhant Pandey
May 13, 2021, 04:27 pm 2 min read
Government panel recommends 12-16 week gap between Covishield doses
Currently, the dose-gap for Covishield is four to eight weeks.

A government expert panel has reportedly recommended raising the time gap between two doses of the COVID-19 vaccine Covishield to 12-16 weeks. Currently, the gap between two doses is kept between four to eight weeks. Covishield—developed by Oxford University and AstraZeneca and manufactured by the Serum Institute of India—is one of the two vaccines being used in India's vaccination drive.

Details
No changes suggested for COVAXIN

Sources informed the news agency PTI that the National Technical Advisory Group on Immunisation (NTAGI) has recommended increasing the gap between two doses of Covishield vaccine to 12-16 weeks. The panel did not suggest any changes for the time interval for the two doses of COVAXIN, which remains at four to six weeks. Bharat Biotech's COVAXIN is the second vaccine in use in India.

Expert
'No data suggests more breakthrough infections by increasing dose-gap'

Writing in The Indian Express in April, Dr. Gagandeep Kang argued that there is no data suggesting a greater number of post-vaccination breakthrough infections between dose intervals of four, eight, or 12 weeks. Dr. Kang is a microbiology professor at Christian Medical College, Vellore. Citing vaccination data from the United Kingdom, she said, "What we're seeing there is good protection with the first dose."

Details
Defer vaccination for 6 months after COVID-recovery: Panel

The NTAGI also recommended that those having laboratory test-proven SARS-CoV-2 illness should defer COVID-19 vaccination for six months after recovery, sources told PTI. The panel further suggested that pregnant women may be offered the choice to take any COVID-19 vaccine, the sources informed the news agency. Lactating women can be inoculated any time after delivery, the panel reportedly suggested.

Background
Covishield dose-gap was increased up to 8 weeks in March

Initially, for Covishield, an interval of four to six weeks was recommended between the two doses. However, taking note of increased protection with a dose gap of six-eight weeks, the interval was increased to four-eight weeks in March. In April, SII CEO Adar Poonawalla had said that Covishield is 90% effective if the two doses are given 2.5-3 months apart.

Information
Vaccine 81.3% effective with 12-week dose gap: Study

In February, a study published in The Lancet had stated that the vaccine is 55.1% effective when the two doses are administered with a gap of less than six weeks. When the dose gap is over 12 weeks, the efficacy increase to 81.3%, it said.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Siddhant Pandey
Siddhant Pandey
Twitter
Siddhant Pandey covers national and health news at NewsBytes. He has over five years of experience working as a multimedia journalist covering hard news in New Delhi. He was previously employed with The Indian Express and News World India and has juggled roles as a correspondent, copy editor, and video producer. He holds a Bachelor’s degree in Biotechnology from the Jaypee Institute of Information Technology, Noida.
Latest
Vaccine
Coronavirus
Serum Institute of India
Covishield
Related
Latest
Centre reinstates J&K's Shah Faesal as IAS officer: Details here
Centre reinstates J&K's Shah Faesal as IAS officer: Details here India
IPL 2022, LSG beat PBKS: List of records broken
IPL 2022, LSG beat PBKS: List of records broken Sports
Centre denies asking Bharat Biotech to address WHO's COVAXIN suspension
Centre denies asking Bharat Biotech to address WHO's COVAXIN suspension India
2022 Badminton Asia Championships: PV Sindhu storms into semi-finals
2022 Badminton Asia Championships: PV Sindhu storms into semi-finals Sports
Lankan President Gotabaya Rajapaksa to form interim government: Details here
Lankan President Gotabaya Rajapaksa to form interim government: Details here World
Vaccine
India inching closer to launching its first dengue vaccine
India inching closer to launching its first dengue vaccine Technology
National Vaccination Day 2022: Know theme, history, significance
National Vaccination Day 2022: Know theme, history, significance Lifestyle
DCGI approves emergency use of Covovax in children above 12
DCGI approves emergency use of Covovax in children above 12 India
Govt panel okays phase-3 trials of Covovax as booster dose
Govt panel okays phase-3 trials of Covovax as booster dose India
COVID-19 pandemic might end in Europe after Omicron's takeover: WHO
COVID-19 pandemic might end in Europe after Omicron's takeover: WHO World
More News
Coronavirus
COVID-19: India logs 3,303 new cases; 39 more deaths
COVID-19: India logs 3,303 new cases; 39 more deaths India
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man India
COVID-19 vaccine precautionary dose available for 18+ from April 10
COVID-19 vaccine precautionary dose available for 18+ from April 10 India
COVID-19 survivors at risk of developing serious blood clots: Study
COVID-19 survivors at risk of developing serious blood clots: Study Technology
COVID-19: India reports 1,660 new cases, 4,100 more deaths
COVID-19: India reports 1,660 new cases, 4,100 more deaths India
More News
Serum Institute of India
COVID-19 vaccine precautionary dose service charge capped at Rs. 150
COVID-19 vaccine precautionary dose service charge capped at Rs. 150 India
Only faster COVID-19 vaccinations can end pandemic: Adar Poonawalla
Only faster COVID-19 vaccinations can end pandemic: Adar Poonawalla India
SII to launch COVID-19 vaccine for children in 6 months
SII to launch COVID-19 vaccine for children in 6 months India
COVID-19 vaccine: Study finds AstraZeneca booster jab safe, effective
COVID-19 vaccine: Study finds AstraZeneca booster jab safe, effective Technology
Are Indian vaccines effective against Omicron? Here's what manufacturers say
Are Indian vaccines effective against Omicron? Here's what manufacturers say India
More News
Covishield
COVAXIN, Covishield will now be available in hospitals and clinics
COVAXIN, Covishield will now be available in hospitals and clinics India
COVID-19: India reports 9K+ infections; 477 more deaths
COVID-19: India reports 9K+ infections; 477 more deaths India
No quarantine for fully vaccinated Indians in UK from Monday
No quarantine for fully vaccinated Indians in UK from Monday India
Date of birth on Co-WIN certificates for passengers traveling abroad
Date of birth on Co-WIN certificates for passengers traveling abroad India
UK recognizes Covishield, but Indians still need to quarantine
UK recognizes Covishield, but Indians still need to quarantine World
More News
Related
COVID-19: How states are ensuring people get their second doses
COVID-19: How states are ensuring people get their second doses India
US: Pfizer-BioNTech COVID-19 vaccine officially granted full approval by FDA
US: Pfizer-BioNTech COVID-19 vaccine officially granted full approval by FDA World
Pfizer-BioNTech COVID-19 vaccine to get US-FDA's full approval next week
Pfizer-BioNTech COVID-19 vaccine to get US-FDA's full approval next week World
Expert panel recommends emergency use authorization for Zydus's three-dose vaccine
Expert panel recommends emergency use authorization for Zydus's three-dose vaccine India
Next News Article
Next News Article

Love India news?

Subscribe to stay updated.

India Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022